Medical Transcription Billing Revenue, Profits - MTBC Annual Income Statement

Add to My Stocks
$5.06 $0.01 (0.2%) MTBC stock closing price Oct 12, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Medical Transcription Billing stock price alone is not sufficient. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. Like any other income statement, the MTBC income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue growth of 29.89% when compared to the same period in the past. Along with Medical Transcription Billing assets and Medical Transcription Billing free cash flow, Medical Transcription Billing profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $-5.56M and the 2017 revenue is $31.81M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Medical Transcription Billing Revenues or Net Sales
31.81M24.49M23.07M18.3M10.47M10.01M
Cost Of Goods Sold (COGS)17.67M13.41M11.63M10.63M4.27M4.25M
Medical Transcription Billing Gross Profit
14.13M11.07M11.44M7.66M6.19M5.76M
Research & Development Expense1.08M-----
Selling General & Admin Expense13.27M12.96M10.65M8.38M4.99M4.66M
Income Before Depreciation Depletion Amortization-0.22M-2.79M--1.24M--
Depreciation Depletion Amortization4.29M5.1M4.59M2.79M--
Non Operating Income--0.01M--0.1M--
Interest Expense1.32M-----
Medical Transcription Billing Pretax Income
-5.49M-8.59M-4.54M-4.33M-0.03M-
Provision for Income Taxes------
MinorityInterest------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations-5.56M-8.79M-4.68M-4.5M-0.17M-
Extraordinary Items & Discontinued Operations------
Medical Transcription Billing Profit/ Loss (Net Income)
-5.56M-8.79M-4.68M-4.5M-0.17M-
Average Shares used to compute Diluted EPS11.01M10.04M9.73M7.09M10.98M-
Average Shares used to compute Basic EPS11.01M10.04M9.73M7.09M10.98M-
Income Before Nonrecurring Items-1.45M-3.91M-2.01M-2.61M-2.45M-
Income from Nonrecurring Items-4.11M-4.89M-2.68M-1.9M--
Medical Transcription Billing Earnings Per Share Basic Net
-0.69-0.95-0.50-0.64-0.22-
Medical Transcription Billing Earnings Per Share Diluted Net
-0.69-0.95-0.50-0.64-0.22-
EPS Diluted Before Nonrecurring Items-0.13-0.38-0.19-0.23-0.22-
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common0.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on Medical Transcription Billing stock analysis. An investor must check the following items in an income statement:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Medical Transcription Billing revenue chart implies that the company is growing. It has been the case with Medical Transcription Billing. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like Medical Transcription Billing try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The MTBC financials along with Medical Transcription Billing historical stock prices provide a lot of details about the firm.

Medical Transcription Billing Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
1.8
Dividend Yield
0%